Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with chagas' disease

Clinical and Vaccine Immunology

Volumn 16, Issue 5, 2009, Pages 660-666

  Dhiman, Monisha ^a   Estrada Franco, Jose Guillermo ^a   Pando, Jasmine M ^a   Ramirez Aguilar, Francisco J ^a   Spratt, Heidi ^b   Vazquez Corzo, Sara ^c   Perez Molina, Gladys ^c   Gallegos Sandoval, Rosa ^d   Moreno, Roberto ^d   Garg, Nisha Jain ^a,e  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSIDAD AUTÓNOMA DE CHIAPAS   (Mexico)

^c Chiapas State Health Services   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ADVANCED OXIDATION PROTEIN PRODUCT; HYPOCHLOROUS ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOPEROXIDASE; NITRATE; NITRITE; PEROXYNITRITE; PROTOZOON ANTIBODY; TOSYLCHLORAMIDE SODIUM; XANTHINE OXIDASE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHAGAS DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MEXICO; NITROSATIVE STRESS; OXIDATIVE STRESS; PRIORITY JOURNAL; RURAL POPULATION; SCREENING; SEROPREVALENCE; TRYPANOSOMA CRUZI;

ANIMALS; ANTIBODIES, PROTOZOAN; CHAGAS DISEASE; HUMANS; MEXICO; NITRIC OXIDE SYNTHASE TYPE II; NITROSATION; OXIDATION-REDUCTION; PEROXIDASE; PREVALENCE; PROTEINS; TRYPANOSOMA CRUZI; XANTHINE OXIDASE;

EID: 66849126219     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00019-09     Document Type: Article

References (48)

1. Babior, B. M. 1999. NADPH oxidase: an update. Blood 93:1464-1476.
2. Baskol, G., H. Demir, M. Baskol, E. Kilic, F. Ates, C. Karakukcu, and M. Ustdal. 2006. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochem. Funct. 24:307-311.
3. Berry, C. E., and J. M. Hare. 2004. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J. Physiol. 555:589-606.
4. Bhatia, V., M. Sinha, B. Luxon, and N. Garg. 2004. Utility of Trypanosoma cruzi sequence database for the identification of potential vaccine candidates: in silico and in vitro screening. Infect. Immun. 72:6245-6254.
5. Bian, K., Y. Ke, Y. Kamisaki, and F. Murad. 2006. Proteomic modification by nitric oxide. J. Pharmacol. Sci. 101:271-279.
6. Bradley, P. P., D. A. Priebat, R. D. Christensen, and G. Rothstein. 1982.Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Investig. Dermatol. 78:206-209.
7. Butterfield, D. A., T. Koppal, B. Howard, R. Subramaniam, N. Hall, K Hensley, S. Yatin, K. Allen, M. Aksenov, M. Aksenova, and J. Carney. 1998. Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-buty\- alpha-phenylnitrone and vitamin E. Ann. N. Y. Acad. Sci. 854:448-462.
8. Cardoni, R. L., M. I. Antunez, C. Morales, and I. R. Nantes. 1997. Release of reactive oxygen species by phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 56:329-334.
9. Chang, P. Y., T. L. Wu, C. C. Hung, K. C. Tsao, C. F. Sun, L. L. Wu, and J. T.Wu. 2006. Development of an ELISA for myeloperoxidase on microplate: normal reference values and effect of temperature on specimen preparation. Clin. Chim. Acta 373:158-163.
10. Chen, L., T. Watanabe, H. Watanabe, and F. Sendo. 2001. Neutrophil depletion exacerbates experimental Chagas' disease in BALB/c, but protects C57BL/6 mice through modulating the Th1/Th2 dichotomy in different directions. Eur. J. Immunol. 31:265-275.
11. Cross, A. R., J. L. Yarchover, and J. T. Curnutte. 1994. The superoxide- generating system of human neutrophils possesses a novel diaphorase activity. Evidence for distinct regulation of electron flow within NADPH oxidase by p67-phox and p47-phox. J. Biol. Chem. 269:21448-21454.
12. de Oliveira, T. B., R. C. Pedrosa, and D. W. Filho. 2007. Oxidative stress in chronic cardiopathy associated with Chagas disease. Int. J. Cardiol. 116:357-363.
13. Dhiman, M., E. S. Nakayasu, Y. H. Madaiah, J.-J. Wen, I. C. Almeida, and N. J. Garg. 2008. Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: implications in Chagas disease. Am. J. Pathol. 173:728-740.
14. Garg, N. 2005. Mitochondrial disorders in chagasic cardiomyopathy. Front. Biosci. 10:1341-1354.
15. Gomes, J. A., L. M. Bahia-Oliveira, M. O. Rocha, O. A. Martins-Filho, G. Gazzinelli, and R. Correa-Oliveira. 2003. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect. Immun. 71:1185-1193.
16. Hartl, D., S. Krauss-Etschmann, B. Koller, P. L. Hordijk, T. W. Kuijpers, F. Hoffmann, A. Hector, F. Eber, V. Marcos, I. Bittmann, O. Eickelberg, M. Griese, and D. Roos. 2008. Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. J. Immunol. 81:8053-8067.
17. Hernandez, S. M., R. A. Kolliker-Frers, M. S. Sanchez, G. Razzitte, R. D. Britos, M. E. Fuentes, and M. N. Schwarcz de Tarlovsky. 2009. Antiprolif- erative effect of sera from chagasic patients on Trypanosoma cruzi epimas- tigotes. Involvement of xanthine oxidase. Acta Trop. 109:219-225.
18. Kaneda, H., J. Taguchi, K. Ogasawara, T. Aizawa, and M. Ohno. 2002. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 162:221-225.
19. Kirchhoff, L. V., L. M. Weiss, M. Wittner, and H. B. Tanowitz. 2004. Parasitic diseases of the heart. Front. Biosci. 9:706-723.
20. Klebanoff, S. J. 1999. Myeloperoxidase. Proc. Assoc. Am. Physicians 111: 383-389.
21. Macao, L. B., D. W. Filho, R. C. Pedrosa, A. Pereira, P. Backes, M. A. Torres, and T. S. Frode. 2007. Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease. Int. J. Car- diol. 123:43-49.
22. Malvezi, A. D., R. Cecchini, F. de Souza, C. E. Tadokoro, L. V. Rizzo, and P. Pinge-Filho. 2004. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection. FEMS Immunol. Med. Microbiol. 41:69-77.
23. Marnett, L. J. 2000. Oxyradicals and DNA damage. Carcinogenesis 21:361-370.
24. Mazariego-Arana, M. A., V. M. Monteon, M. A. Ballinas-Verdugo, N. Her- nandez-Becerril, R. Alejandre-Aguilar, and P. A. Reyes. 2001. Seropreva- lence of human Trypanosoma cruzi infection in different geographic zones of Chiapas, Mexico. Rev. Soc. Bras. Med. Trop. 34:453-458.
25. Melo, R. C., D. L. Fabrino, H. D'Avila, H. C. Teixeira, and A. P. Ferreira. 2003. Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi in vivo. Cell Biol. Int. 27:853-861.
26. Munoz-Fernandez, M. A., M. A. Fernandez, and M. Fresno. 1992. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol. Lett. 33:35-40.
27. Naviliat, M., G. Gualco, A. Cayota, and R. Radi. 2005. Protein 3-nitroty- rosine formation during Trypanosoma cruzi infection in mice. Braz. J. Med. Biol. Res. 38:1825-1834.
28. Noyan, T., A. Guler, M. R. Sekeroglu, and M. Kamaci. 2006. Serum advanced oxidation protein products, myeloperoxidase and ascorbic acid in pre-eclampsia and eclampsia. Aust. N. Z. J. Obstet. Gynaecol. 46:486-491.
29. Pinge-Filho, P., J. P. Peron, T. R. de Moura, R. A. Menolli, V. K. Graca, D. Estevao, C. E. Tadokoro, J. V. Jankevicius, and L. V. Rizzo. 2005. Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide. Immunol. Lett.96:283-290.
30. Plata, F., F. Garcia Pons, and H. Eisen. 1984. Antigenic polymorphism of Trypanosoma cruzi: clonal analysis of trypomastigote surface antigens. Eur. J. Immunol. 14:392-409.
31. Sanchez, B., V. Monteon, P. A. Reyes, and B. Espinoza. 2001. Standardization of micro-enzyme-linked immunosorbent assay (ELISA) and Western blot for detection of Trypanosoma cruzi antibodies using extracts from Mexican strains as antigens. Arch. Med. Res. 32:382-408.
32. Schopfer, F. J., P. R. Baker, and B. A. Freeman. 2003. NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response? Trends Biochem. Sci. 28:646-654.
33. Silva, J. S., F. S. Machado, and G. A. Martins. 2003. The role of nitric oxidein the pathogenesis of Chagas disease. Front. Biosci. 8:s314-s325.
34. Terada, L. S., J. A. Leff, and J. E. Repine. 1990. Measurement of xanthine oxidase in biological tissues. Methods Enzymol. 186:651-666.
35. Van Der Vliet, A., M. N. Nguyen, M. K. Shigenaga, J. P. Eiserich, G. P. Marelich, and C. E. Cross. 2000. Myeloperoxidase and protein oxidation in cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L537- 546.
36. Vespa, G. N., F. Q. Cunha, and J. S. Silva. 1994. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 62:5177-5182.
37. Weinbroum, A., V. G. Nielsen, S. Tan, S. Gelman, S. Matalon, K. A. Skinner, E. Jr. Bradley, and D. A. Parks. 1995. Liver ischemia-reperfusion increases pulmonary permeability in rat: role of circulating xanthine oxidase. Am. J.Physiol. 268:G988-G996.
38. Wen, J.-J., V. Bhatia, V. L. Popov, and N. J. Garg. 2006. Phenyl-alpha-tert- butyl nitrone reverses mitochondrial decay in acute Chagas disease. Am. J.Pathol. 169:1953-1964.
39. Wen, J.-J., and N. Garg. 2004. Oxidative modifications of mitochondrial respiratory complexes in response to the stress of Trypanosoma cruzi infection. Free Radic. Biol. Med. 37:2072-2081.
40. Wen, J.-J., G. Vyatkina, and N. Garg. 2004. Oxidative damage during chagasic cardiomyopathy development: role of mitochondrial oxidant release and inefficient antioxidant defense. Free Radic. Biol. Med. 37:1821-1833.
41. Wen, J.-J., P. C. Yachelini, A. Sembaj, R. E. Manzur, and N. Garg. 2006. Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients. Free Radic. Biol. Med. 41:270-276.
42. Wen, J.-J., M. Dhiman, E. B. Whorton, and N. J. Garg. 2008. Tissue-specific oxidative imbalance and mitochondrial dysfunction during Trypanosoma cruzi infection in mice. Microbes Infect. 10:1201-1209.
43. White, C. R., V. Darley-Usmar, W. R. Berrington, M. McAdams, J. Z. Gore, J. A. Thompson, D. A. Parks, M. M. Tarpey, and B. A. Freeman.1996. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc. Natl. Acad. Sci. USA93:8745-8749.
44. Winterbourn, C. C., and A. J. Kettle. 2000. Biomarkers of myeloperoxidase- derived hypochlorous acid. Free Radic. Biol. Med. 29:403-409.
45. Witko-Sarsat, V., M. Friedlander, C. Capeillere-Blandin, T. Nguyen-Khoa, A. T. Nguyen, J. Zingraff, P. Jungers, and B. Descamps-Latscha. 1996.Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49:1304-1313.
46. Woods, A. A., S. M. Linton, and M. J. Davies. 2003. Detection of HOCl mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochem. J. 370:129-135.
47. World Health Organization. 2002. Control of Chagas disease: second report of the W. H. O. expert committee. UNDP/World Bank/WHO, Geneva, Switzerland.
48. Zacks, M. A., J.-J. Wen, G. Vyatkina, V. Bhatia, and N. Garg. 2005. An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress. Ann. Acad. Bras. Cienc. 77:695-115.